newsfilter
← Latest News
PR Newswire·

INVO Provides Preliminary Update on FY2022 Financial Results

SARASOTA, Fla., March 30, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment